Filtros : "2006" "Journal of Pharmaceutical and Biomedical Analysis" "FCFRP" Removidos: "601" "Galvão, A. F." "Watanabe, Evandro" "BRAGA, GILBERTO LEITE" Limpar

Filtros



Refine with date range


  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP

    Subjects: FARMACOCINÉTICA, COMPOSTOS HETEROCÍCLICOS, GRAVIDEZ

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PAPINI, Olga et al. Kinetic disposition of larozepam with focus on the glucoronidation capacity, transplacental transfer in parturients and racemization in biological samples. Journal of Pharmaceutical and Biomedical Analysis, v. 40, n. 2, p. 397-403, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2005.07.021. Acesso em: 21 out. 2024.
    • APA

      Papini, O., Cunha, S. P. da, Mathes, Â. do C. da S., Bertucci, C., Moisés, E. C. D., Duarte, L. de B., et al. (2006). Kinetic disposition of larozepam with focus on the glucoronidation capacity, transplacental transfer in parturients and racemization in biological samples. Journal of Pharmaceutical and Biomedical Analysis, 40( 2), 397-403. doi:10.1016/j.jpba.2005.07.021
    • NLM

      Papini O, Cunha SP da, Mathes  do C da S, Bertucci C, Moisés ECD, Duarte L de B, Cavalli R de C, Lanchote VL. Kinetic disposition of larozepam with focus on the glucoronidation capacity, transplacental transfer in parturients and racemization in biological samples [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2006 ; 40( 2): 397-403.[citado 2024 out. 21 ] Available from: https://doi.org/10.1016/j.jpba.2005.07.021
    • Vancouver

      Papini O, Cunha SP da, Mathes  do C da S, Bertucci C, Moisés ECD, Duarte L de B, Cavalli R de C, Lanchote VL. Kinetic disposition of larozepam with focus on the glucoronidation capacity, transplacental transfer in parturients and racemization in biological samples [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2006 ; 40( 2): 397-403.[citado 2024 out. 21 ] Available from: https://doi.org/10.1016/j.jpba.2005.07.021
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP

    Assunto: FARMACOLOGIA CLÍNICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PAPINI, Olga et al. Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples. Journal of Pharmaceutical and Biomedical Analysis, v. 40, p. 389-396, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2005.07.033. Acesso em: 21 out. 2024.
    • APA

      Papini, O., Bertucci, C., Cunha, S. P. da, Santos, N. A. G. dos, & Lanchote, V. L. (2006). Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples. Journal of Pharmaceutical and Biomedical Analysis, 40, 389-396. doi:10.1016/j.jpba.2005.07.033
    • NLM

      Papini O, Bertucci C, Cunha SP da, Santos NAG dos, Lanchote VL. Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2006 ; 40 389-396.[citado 2024 out. 21 ] Available from: https://doi.org/10.1016/j.jpba.2005.07.033
    • Vancouver

      Papini O, Bertucci C, Cunha SP da, Santos NAG dos, Lanchote VL. Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2006 ; 40 389-396.[citado 2024 out. 21 ] Available from: https://doi.org/10.1016/j.jpba.2005.07.033
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCFRP

    Assunto: QUÍMICA ANALÍTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARQUELE, Franciane Delfin et al. Propolis extract release evaluation from topical formulations by chemiluminescence and HPLC. Journal of Pharmaceutical and Biomedical Analysis, v. 41, p. 461-468, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2005.12.022. Acesso em: 21 out. 2024.
    • APA

      Marquele, F. D., Oliveira, A. R. M., Bonato, P. S., Lara, M. G., & Fonseca, M. J. V. (2006). Propolis extract release evaluation from topical formulations by chemiluminescence and HPLC. Journal of Pharmaceutical and Biomedical Analysis, 41, 461-468. doi:10.1016/j.jpba.2005.12.022
    • NLM

      Marquele FD, Oliveira ARM, Bonato PS, Lara MG, Fonseca MJV. Propolis extract release evaluation from topical formulations by chemiluminescence and HPLC [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2006 ; 41 461-468.[citado 2024 out. 21 ] Available from: https://doi.org/10.1016/j.jpba.2005.12.022
    • Vancouver

      Marquele FD, Oliveira ARM, Bonato PS, Lara MG, Fonseca MJV. Propolis extract release evaluation from topical formulations by chemiluminescence and HPLC [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2006 ; 41 461-468.[citado 2024 out. 21 ] Available from: https://doi.org/10.1016/j.jpba.2005.12.022

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024